How will 2020 change US healthcare? InCrowd’s physicians weigh in on what the new year will bring. Join Diane Hayes, PhD, InCrowd Co-Founder and Board Member and Daniel S. Fitzgerald, InCrowd CEO and President, for InCrowd’s 2020 Healthcare Predictions Webinar. Register Now!
Learn how we used a tiered model-based approach of a bi-specific antibody to appropriately cover multiple antigen pairs to help teams with informed antibody design, prioritization of experiments, and triaging of challenging antigen pairs. Register today.
This new year, take a fresh look at your monitoring processes and learn how to improve efficiency across the entire monitoring lifecycle. Register for the webinar here.
The focus of this webinar will be on the design and process approach for next generation large volume delivery systems for prefilled cartridge delivery, as well as on providing an overview of key critical product requirements, such as compatibility with sensitive drug products, system functionality, and fill-finish implementation. Register now.
This webinar reveals results from a recent industry survey that sought to gain insight on trial sponsors’ perspective on offering a DTP option and their current level of awareness and understanding of any factors that may influence their ability to do so. Register now to learn more.
Each year, PwC's Health Research Institute (HRI) names the top issues for the health industry in the coming year. What made the list for 2020? Join HRI for a discussion of the most important trends for providers, insurers, pharma/life sciences and employers. Register now.
Regardless of the assigned FDA expedited approval designation and approach, the key action items should be: the assurance of a detail-oriented plan and the adaption of a “forward-thinking” approach that will assist in any future challenges and opportunities for growth of each project. Click here to download the Executive Summary.
Get expert insights on strategies to implement flexible manufacturing and different technologies that are easily scalable and reproducible. Click here to download the presentation.
Tufts Center for the Study of Drug Development (CSDD) white paper sharing study results that indicate Quotient Sciences’ Translational Pharmaceutics® platform reduces development times by more than 12 months and lowers R&D costs by more than $100 million per approved new drug, compared to traditional multi-vendor development paradigms. Download the whitepaper.
Are there certain types of clinical sponsors and studies that are at greater risk of experiencing supply challenges? This webinar will explore aspects of the study protocol that can directly influence clinical supply strategy and how sponsors can proactively understand and address clinical supply-related risks. Register now.
As emerging modalities transform the needs of life science R&D, how can biotech and pharma companies use modern software approaches to increase productivity and reach breakthroughs faster? Click here to download the whitepaper.
This paper discusses some of the challenges that the GDPR will introduce, with a particular focus on its requirements for obtaining verifiable, unambiguous consent. It explores what businesses will need to do to obtain valid consents from individuals, and how third-party tools can help address these requirements.
In this webinar, snapIoT and industry thought leaders discuss key criteria to successfully utilize Telemedicine in Clinical Trials. Learn use cases for telemedicine in study design, how to evaluate vendors, and see a demo of snapIoT's modern and user-friendly Telemedicine solution. Register Today.
A digital transformation is taking place in the life sciences industry, from research laboratories to manufacturing facilities. But there has always been a gap in these technologies: the inability to effectively manage transactions within an organization and to extend beyond its four walls to collaborative partners such as CROs, customers, and other suppliers. Download the whitepaper to learn how this challenge was addressed.
In life sciences, blockbuster products are few and far between. As a result, accelerating value, from R&D to commercialization, is critical to enhancing profits. Download this paper to learn how you can fully digitize all paper processes. By doing so, you will see shorter cycle times, reduced development costs, and greater customer satisfaction.
Read our white paper, “Digital Disruption in Biopharma: How Digital Transformation can reverse declining ROI on R&D,” to discover:
- The potential and impact of transformative technologies
- How they might transform trial operations and multiply ROI on R&D
- The resources, expertise and organisational changes required to best utilise these technologies
Innovations in therapeutic development have advanced beyond traditional product launch strategies. In every step of the product lifecycle, we see pockets of transformation. The problem is exactly that – “pockets” of transformation. How are your strategies converting innovation into value for patients? Download the white paper.
Drexel University’s online graduate programs in biomedicine, clinical research, drug discovery, and molecular medicine were developed with working professionals in mind, providing you with the education, practical skills, and competitive edge you need to be successful in your career. Learn more.
Obtaining feedback from Life Sciences organizations are key in the delivery of actionable insights that our target customers come to expect. Our goal is to assess how far the adoption of AI technology has come in Life Sciences. Let your voice be heard in this survey.
Read about different perspectives on how telemedicine solutions will change the future landscape of decentralized and fully virtual clinical trials. Learn how snapIoT’s proprietary Telemedicine solution addresses the barriers mentioned by industry thought leaders and how snapIoT can accelerate the successful deployment of self-service technology in your next study.
In this whitepaper, we look at robust strategies that pharmaceutical manufacturers can adopt to protect their supply chain. Innovative solutions, such as on-dose microtags, are now being used to authenticate products; this mitigates counterfeiting, product diversion and helps to monitor returned product, quality control and recall. Download the whitepaper to learn more!
From the basics such as service level expectations for couriers versus integrators, to how to evaluate domestic and international lanes, and finally – how to balance risk and cost, this webinar will help you understand how to start tackling your clinical supply chain. Register now.
Drug development is an increasingly challenging industry with R&D returns declining, regulatory hurdles increasing, and the competition for funding ever fierce. Metabolomics is an essential technology for helping you overcome these challenges by bringing a focused approach to your data discovery while uncovering actionable insights. Read the whitepaper today!
Join us as an interdisciplinary group of experts from the Digital Medicine Society (DiMe) provide a brief introduction to core concepts and terms that define digital medicine, along with practical tips for implementation and case examples.
Today, the rise of a new generation of robotic, precision, and surgical devices has created vast stores of video, imaging, and electronic surgical notes, prompting the question: How do you leverage these datasets and improve patient treatments and outcomes? Register now to learn how a connected data platform offers a definitive answer.
This whitepaper highlights the challenges of implementing the right digital twin strategy while providing key use cases in the manufacturing domain for which a digital twin is extremely useful and several examples of technology trends that will shape the future. Download now.
Why should the primary container system be considered an excipient? Register for West’s webinar on December 5, to gain insight on considerations that should be made to mitigate packaging risks early in the drug development process!
In this webinar, AstraZeneca and Catalent Biologics experts will share a case study on a 30-day commercial launch plan for a product into new markets and why this approach was important for patients. Register now.
Hear how ICON, Lotus Clinical Research, and Bioforum are speeding database builds and automating reporting tasks for data management. Learn how to reap the rewards of a straightforward build and a modern EDC during this webinar. Register now.
In this Q&A, four Catalent Biologics experts share how scale-up, regulatory expectations, demand forecasting and process validation all play a role in the success of a biologic when embarking upon the commercial manufacturing journey. Click here to learn more!
It's clear that healthcare prices weigh heavily on the minds of Americans, and the time has come for the pharmaceutical industry to take the reins of the prescription drug pricing dialogue with consumers. Download this whitepaper now to learn more about prescription drug price transparency and its role in creating affordability, accessibility, and accountability.
Accenture experts will explore the emergence of SaMD as a new class of medical device and discuss the potential challenges that biopharma companies face in the development of these solutions. Register for this webinar now.
Pharmaceutical and medical device manufacturers strive towards a culture of zero – zero hazards, zero defects, and zero waste. At the same time, they must meet GxP requirements, update antiquated systems and processes, and address the demands of an increasingly tech savvy workforce. Register now to learn more about the role that content management plays in pharmaceutical manufacturing.
Managing the volume and variability of healthcare data is a challenge for many life sciences organizations looking to modernize clinical trials. From data management to IoT to high-performance computing and machine learning, life sciences organizations are working with Amazon Web Services (AWS) and AWS Partners to develop life science solutions that are scalable, global, and secure. Click here to download the eBook!
This whitepaper explores how a data lake, enabled by AI and ML, can be used to ingest, aggregate, standardize and provide secured data access and the value it can deliver in reducing risk and driving efficiency, speed and cost savings. Download now.
Join industry experts as they analyze the critical role of innovation in OTC products, and strategies for achieving it. Register now to learn more about survey insights, market trends, and latest technologies.
Liquid-filled capsule technology has a proven record for addressing complex API formulation challenges, but also offers a simple and effective pathway to the clinic. Register now to learn more about lipid-based formulations.
The transformations now taking place in the emerging field of connected packaging have the potential to address all these product challenges—protection, engagement, traceability—while delivering powerful supply chain insight. Register now to learn more.
Why is diversity in clinical trials important? Minority populations are more likely to be diagnosed with certain cancers, stroke, diabetes, and are more likely to die prematurely than White Americans. Health disparities by race and ethnicity could increase if minority populations are not included in clinical trials.
Register now to learn who is participating in clinical trials and why.
Integrated Imaging and EDC ensures the right data is presented to the right users at the right time, free from manual intervention. Taking data reconciliation to a whole new level means your trial not only saves time, resources and cost, but also drastically reduces your clinical trial risk. Register now to learn more.
Fully integrated CDMO for biologics bulk drug substance and sterile injectable drug products. Benefit from our turnkey upstream and downstream support for eukaryotic, microbial and viral expression as well as finished dose services.
- Cell, Viral, and Microbial
- Single-Use Platform (2L to 4000L Scale)
- Process & Analytical Development
- Parenteral Formulation Development
- Fill/Finish Capabilities
- Vials & Pre-Filled Syringes
- Liquid & Lyophilized products
To learn more, visit us at CPhI WW, Stand 120A50 or contact us at [email protected]
When consistent supply for your patients is critical, you can rely on an ANI Global Source collaboration. ANI Global Source is a specialty CDMO supporting late stage development and commercial pharmaceutical manufacture of:
- Oral dosage forms
- Creams & Gels
- Potent compounds
- Class II controlled substances
Manufacturing your product requires more than raw materials and established processes. At ANI Global Source, expertise, safety, reliability, and integrity are at the core of everything we produce. Visit us at booth 121H63 to learn more.
In this webinar, we'll highlight some of these approaches and demonstrate how data and analytics can be used to gain a competitive advantage and create differentiation. Register now.
Formulation challenges. Clinical supply hurdles. Lifecycle management. Risk mitigation. Patent expiry concerns. At BioPharma Solutions, a business unit of Baxter, we know the high-stakes challenges you face in today’s complex parenteral marketplace — and how the work we do is vital to the patients you serve.
If you have an injectable molecule and are looking for sterile contract manufacturing services, we invite you to stop by our stand at CPhI Worldwide in Frankfurt (Hall 12.1, Space F81) to meet with a representative and discuss how we can help you achieve your molecule’s full potential. Learn more.
We assists clients with small molecule cGMP projects from lab to multi-metric ton quantities. Our team provides phase appropriate route and process development solutions for short-term scale-up and long-term manufacturing challenges.
With vast experience in downstream purification techniques (chromatography, crystallization), we have completed 100+ chemical API projects (10 ongoing commercial products), including: complex multi-step synthesis, potent handling, and controlled substances. FDA & Health Canada inspected.
To meet our team at CPhI (booth 121H42), email [email protected]!
Discover an approach to solubility and bioavailability enhancement of poorly water soluble drug molecules, approaches to aqueous-based spray drying of bio-pharmaceuticals as well as small molecules intended for inhalation delivery. Join us for this webinar to learn more.
Register for this webinar to learn about the tools and technologies for creating dosage forms such as orally disintegrating tablets (ODTs), multi-particulates, and modified release formulations.
In this interview, Greg Fry, Patient and Consumer Analytics - ZS Associates, discusses consumer data and marketing trends and how to optimize digital campaigns. Watch the video.
In this webinar, you will hear from Alan Louie, Ph.D, Research Director at IDC, Bill Swavely, CIO at Pharm-Olam, and Rama Kondru, Ph.D, CIO at Medidata about the need for a platform approach in clinical research, the rationale for switching from disparate systems to a unified platform, and the benefits that could be realized. Register now.
This webinar will address how the use of technology for deploying data and analytic standards can be utilized to meet the challenge of understanding and comparing findings between studies conducted by different researchers, by facilitating the standardization, transparency, reproducibility, and replicability of RWD research. Register now.
In this webinar, we'll share insights to harness the strategic value of real world data to build optimized drug development programs that minimize the time and cost of sponsor-driven studies. Register now!
Join us for this webinar as we bring together a panel of industry experts to discuss the changing landscape of biosimilar development and how it will affect pricing in the future.
With increasing competition for patients, the ability to effectively and efficiently execute on clinical development plans has increased focus on alternative data sources. In this one-hour session attendees will hear from former FDA leaders and industry experts who will address what Synthetic Control is and how it can be leveraged in clinical development.
Eight years after the FDA issued its guidance of process validation, some still ask the question “Is process characterization optional anymore?” This webinar will cover the basics of process characterization, whether it is optional or not, and what “good” process characterization really looks like. Register now!
As companies face pressure to bring drugs to market quicker & at minimal cost, pharma & biotech companies are outsourcing parts of drug development & manufacturing process. Outsourcing eliminates the need to maintain expensive in-house facilities & provides access to other technologies & expertise. Click here to download the whitepaper today!